NCT05122130 is a Phase 2 clinical trial of Melatonin in Wound Heal, sponsored by Salma Nabil.

Who is sponsoring NCT05122130?

NCT05122130 is sponsored by Salma Nabil.

What drugs are being tested in NCT05122130?

Interventions in NCT05122130: Melatonin, Carbopol.

What condition does NCT05122130 study?

NCT05122130 studies Wound Heal.

Is NCT05122130 still recruiting?

NCT05122130 is currently status unknown. Last updated 26 January 2022.

Last reviewed 2022-01-26 · How we verify

NCT05122130

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Melatonin on Palatal Wound Healing (Randomized Controlled Clinical Trial)

Status unknown Phase 2 Last updated 26 January 2022

What this trial tests

Phase 2 trial testing Melatonin in Wound Heal in 26 participants. Status unknown.

Timeline

20 November 2021

Primary endpoint
20 September 2022

20 December 2022

Quick facts

Lead sponsor	Salma Nabil
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	26
Start date	20 November 2021
Primary completion	20 September 2022
Estimated completion	20 December 2022
Sites	1 location across Egypt

Drugs / interventions tested

Melatonin (MELATONIN) — full drug profile →
Carbopol — full drug profile →

Conditions studied

Wound Heal — all drugs for Wound Heal →

Sponsor

Salma Nabil — full company profile →

Who can join

Adults 20 to 50, any sex, with Wound Heal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the effect of topical melatonin loaded gelatin sponge on donor palatal site healing, after palatal graft harvesting.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Effect of Cellular Senescence in Disease Progression and Transplantation: Immune Cells and Solid Organs.
Kirchner VA, Badshah JS, Hong SK, Martinez O, et al · · 2024 · cited 8× · PMID 37953486 · DOI 10.1097/tp.0000000000004838
Biopolymer Hydrogel-Based Nanocomposites Functionalized with Natural Products for Wound Dressings: Translational Advances in Drug Design, Development, and Therapeutic Wound Care.
Ranatunga B, Sekar M, Hashmi AR, Zahra F, et al · · 2026 · PMID 41884485 · DOI 10.2147/dddt.s578261

Verify or expand the search:

Other trials of Melatonin

Trials testing the same drug.

NCT07221968 — Melatonin for the Treatment of DEE-SWAS · Phase 2 · not yet recruiting
NCT07503600 — The Effect of Adjunctive Melatonin With Colistin in Patients With Multidrug-Resistant Gram-Negative Bacterial Infections · Phase 3 · not yet recruiting
NCT07375342 — Melatonin for Post Tonsillectomy Emergence Agitation in Pediatric · NA · enrolling by invitation
NCT07305350 — EFFICACY OF MELATONIN IN MANAGEMENT OF HYPOXIC ISCHEMIC ENCEPHALOPATHY (HIE) IN NEONATES · Phase 2 · active not recruiting
NCT07096635 — Oral Melatonin With Intra Articular Analgesia on Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction · NA · not yet recruiting

Other recruiting trials for Wound Heal

Currently open trials in the same condition.

NCT07261501 — An Exploratory Research on the Efficacy and Safety of Antibacterial Absorbable Dressing in Chronic Non-healing Wounds · NA · recruiting
NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
NCT06522438 — Hyaluronic Acid and Octenidine Gel as an Adjunct to Non-surgical Periodontal Treatment · NA · recruiting
NCT06841237 — Randomized Controlled Trial on the Efficacy and Safety of Xiang Lei Ointment in Diabetic-related Ulcer Management · NA · recruiting
NCT06563323 — Guselkumab in the Treatment of Adults With Pyoderma Gangrenosum (PG) · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05122130 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Salma Nabil
Last refreshed: 26 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05122130.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing